Cell therapy > 통합검색

통합검색

한빛사

내가 찾은 검색어

1Cell therapy

'Cell therapy' 에 대한 통합검색결과 1,660건입니다.

한빛사1,660건

최신순
관련도순

- 이상남(성균관대학교 나노과학기술원 (SAINT))
- 임용택(성균관대학교)
Focused ultrasound-triggered doxorubicin liposomes reshape tumor microenvironment to boost checkpoint depletion in triple-negative breast cancer model
- J. Control. Release Available online 4 November 2025, 114389 | https://doi.org/10.1016/j.jconrel.2025.114389
- 2025.11
- 바이오·의료융합
- 김종승(고려대학교)
Engineering Supramolecular Assemblies via Metal-Metal Interactions for Biological Applications
- Angew. Chem.-Int. Edit. Nov 03 2025, | https://doi.org/10.1002/anie.202516383
- 2025.11
An in situ immunogenicity-amplifying payload delivery system for immunotherapy of Kirsten rat sarcoma viral oncogene homolog?mutant cancer
- J. Control. Release Available online 1 November 2025, 114380 | https://doi.org/10.1016/j.jconrel.2025.114380
- 2025.11
- 바이오·의료융합
- 조영석(University of Michigan)
- James J. Moon(University of Michigan)
Reprogramming tumor microenvironment via systemic delivery of TLR3 agonist and manganese nanoparticle
- Proc. Natl. Acad. Sci. USA Nov 11 2025, 122 (45) | https://doi.org/10.1073/pnas.2409559121
- 2025.11
- 바이오·의료융합
이채은

동국대학교

고형 종양은 조밀한 세포외기질을 형성하여 물리적 장벽 역할을 수행할 뿐 아니라, 다양한 면역억제성 사이토카인을 분비함으로써 종양 미세환경(Tumor Microenvironment, TME)을 조성합니다. 이러한 TME는 종양 주변 면역세포의 탈진(exhaustion)을 유도하고, 특히 자연살해(Natural Killer, NK)세포의 침윤과 세포독성 기능을 억제하여 종양의 성장과 전이를 촉진합니다. 최근 이러한 고형 종양의 한계를 극복하기 위해 면역세포 기반 치료법이 활발히 연구되고 있으며, 그중에서도 NK 세포는 선천적 세포독성과 MHC 비의존적 인식 능력으로 인해 차세대 면역항암치료제의 주요 후보로 주목받고 있습니다.
- Biomater. Res.
- 2025.11.05
- 이상진(University of Hong Kong)
Homogeneously cross-linked in situ hydrogel enclosing high-density human-cancer cells promotes vascularized in vivo tumor modeling for immune cell the
- Adv. Compos. Hybrid Mater. 01 October 2025 | https://doi.org/10.1007/s42114-025-01429-4
- 2025.10
- 의약학
Gold Nanoturf-Mediated Wireless Photothermal Upregulation of Human Adipose-Derived Stem Cell Spheroids for Synergistic Skin-Wound Closure
- Adv. Sci. Oct 14 2025, | https://doi.org/10.1002/advs.202515490
- 2025.10
- 바이오·의료융합
- 김은주(한국원자력의학원)
Cell?cell interactions as predictive and prognostic markers for drug responses in cancer
- Genome Med. 08 October 2025 | https://doi.org/10.1186/s13073-025-01518-5
- 2025.10
- 바이오·의료융합
- 김형식(Harvard Medical School MGH, 한양대학교)
A Myeloid Cell-Targeted Immunostimulant Cocktail (MyTai) Enhances Cancer Immunotherapy
- ACS Nano Oct 08 2025, | https://doi.org/10.1021/acsnano.5c10081
- 2025.10
- 바이오·의료융합
4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy
- Cell Rep. Med. Oct 03 2025, S2666-3791(25)00481-1 | https://doi.org/10.1016/j.xcrm.2025.102408
- 2025.10
Development of NK Cell-Drug Conjugates via Membrane-installed Liposomes for Pancreatic Cancer Treatment
- Biomater. Res. 29 Oct 2025 | https://doi.org/10.34133/bmr.0285
- 2025.10
- 바이오·의료융합
- 박현정(차의과학대학교, 한양대학교)
- 이재영((주)툴젠, 성균관대학교, 삼성서울병원)
Targeted genome editing of ZKSCAN3 mitigates the neurotoxicity caused by mutant HTT (huntingtin) in a Huntington disease animal model and three-dimens
- Autophagy Oct 10 2025, | https://doi.org/10.1080/15548627.2025.2569965
- 2025.10
- 의약학
- 허동은(University of Pennsylvania)
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors
- Nat. Biotechnol. Oct 17 2025, | https://doi.org/10.1038/s41587-025-02845-z
- 2025.10
- 바이오·의료융합
- 김태민(서울대학교병원, 서울대학교 의과대학)
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer
- N. Engl. J. Med. Oct 17 2025, | https://doi.org/10.1056/NEJMoa2511065
- 2025.10
- 의약학
Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies
- J. Hematol. Oncol. Published: 27 October 2025 | https://doi.org/10.1186/s13045-025-01744-9
- 2025.10
- 의약학
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease
- Cell October 13, 2025 | https://doi.org/10.1016/j.cell.2025.09.010
- 2025.10
- 의약학
- 전홍재(차의과학대학교 분당차병원)
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellu
- J. Immunother. Cancer Oct 05 2025, 13 (10) e010975 | https://doi.org/10.1136/jitc-2024-010975
- 2025.10
- 의약학
Ultrasensitive Detection of PD-L1-Expressing Extracellular Vesicles via Reflection-Mediated Ellipsometry: From Nanoscale Optical Modeling to Immunothe
- Small Oct 30 2025, | https://doi.org/10.1002/smll.202507372
- 2025.10
- 바이오·의료융합
Y-shaped trivalent aptamer for targeted visualization and tracking of reprogrammed astrocytes
- Mater. Today Bio Available online 28 October 2025, 102482 | https://doi.org/10.1016/j.mtbio.2025.102482
- 2025.10
- 바이오·의료융합
Repeatable Photoactive Stent-based Catheter to Enhance Therapeutic Efficacy for Esophageal Carcinoma
- Biomater. Res. 10 Oct 2025 | https://doi.org/10.34133/bmr.0274
- 2025.10
- 바이오·의료융합